MAP3K2 and central nervous system cancer: For example, miR-26a that is upregulated in glioma tissues suppresses PTEN, RB1 and MAP3K2/MEKK2 expression and inhibits c-JUNN-terminal kinase-dependent apoptosis [62,113].